Residential house cleaning is now a $17 billion U.S. business. Maid services have enjoyed fairly steady growth, as an aging U.S. population, time-pressed consumers and Millennials boost demand. The Bureau of Labor Statistics expects continued growth for this occupation, although recessions do affect the business.

The value of the total market is estimated to have grown to a historic peak of $135 billion in 2025, boosted by soaring sales of the popular prescription GLP-1 weight loss drugs. This is a paradigm shift to medical programs, and a major challenge for competing commercial weight loss companies.

The home services industry is huge and diversified, employing millions of workers and thousands of contractors and service providers. The market does feel the effects of recessions, but growth from 2025 to 2030 looks promising as the American housing stock ages.

From routine maintenance to complex renovations, the demand for professional home services is expanding, offering significant opportunities for businesses in this sector.

Demand for mental health services soared with the pandemic and 61 million Americans (more than one in five adults) now have some form of mental illness, with prevalence among adolescents rising sharply.

Professional coaching is no longer niche—it’s mainstream. More Americans than ever are turning to coaches for support with career transitions, work–life balance, technology shifts, personal finance, relationships, health habits, and everyday motivation.

Meditation has become more mainstream in America, with interest soaring during the pandemic for apps like Calm and Headspace.

There are 1.5 million children with autism in America, and the United States is the largest market for autism treatment programs. This is a long-term growth market.

Meal replacements such as shakes and nutrition bars have long been a popular DIY option for American dieters. Retail non-prescription appetite suppressants such as fat burners and other diet pills have also been popular. Both products are easy to obtain, inexpensive, and carry no significant side effects.

The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs.